New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.
Clinical trial results presented for the first time at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuber
Clinical trial results presented in Paris at the Union World Conference on Lung Health showed that a once-daily dose of a widely available antibiotic over six months cut a child’s risk of developing m
Tuberculosis, which is preventable and curable, has reclaimed the title of the world’s leading infectious disease killer, after being supplanted from its long reign by Covid-19. But worldwide, 40 perc